SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001831283-22-000075
Filing Date
2022-11-10
Accepted
2022-11-10 16:33:32
Documents
59
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q adr-20220930.htm   iXBRL 10-Q 1376738
2 EX-10.1 exhibit101-amendmentno1tol.htm EX-10.1 39676
3 EX-31.1 exhibit311-certificationof.htm EX-31.1 16629
4 EX-31.2 exhibit312-certificationof.htm EX-31.2 16669
5 EX-32.1 exhibit321-certificationof.htm EX-32.1 5388
6 EX-32.2 exhibit322-certificationof.htm EX-32.2 5401
12 adr-20220930_g1.gif GRAPHIC 30971
  Complete submission text file 0001831283-22-000075.txt   6008978

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adr-20220930.xsd EX-101.SCH 36950
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adr-20220930_cal.xml EX-101.CAL 58769
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adr-20220930_def.xml EX-101.DEF 161816
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adr-20220930_lab.xml EX-101.LAB 469452
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adr-20220930_pre.xml EX-101.PRE 286075
53 EXTRACTED XBRL INSTANCE DOCUMENT adr-20220930_htm.xml XML 1018013
Mailing Address 103 CARNEGIE CENTER DRIVE, SUITE 309 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER DRIVE, SUITE 309 PRINCETON NJ 08540 (609) 486-2308
LianBio (Filer) CIK: 0001831283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40947 | Film No.: 221377863
SIC: 2834 Pharmaceutical Preparations